多重耐药
PI3K/AKT/mTOR通路
癌症研究
基因沉默
结直肠癌
蛋白激酶B
生长因子
细胞内
癌细胞
细胞生长
信号转导
癌症
胰岛素样生长因子
抗药性
生物
化学
药理学
受体
细胞生物学
内科学
医学
生物化学
遗传学
基因
作者
Ke Shen,Daling Cui,Liyun Sun,Yanhua Lü,Mingquan Han,Jianwen Liu
摘要
The emergence of multidrug resistance (MDR) in cancer cells has made many of the currently available chemotherapeutic agents ineffective. However, the mechanism involved in mediating this effect is not yet fully understood. Here, we found the overexpression of type I insulin-like growth factor receptor (IGF-IR) in established colorectal MDR cells. Specific siRNA of IGF-IR decreases cell proliferation, exert synergistic effect with anticancer drugs. The downstream signaling of IGF-IR, PI3K/AKT pathway, was altered upon IGF-IR silencing. The expression of multidrug-resistance-associated protein 2 (MRP-2) was suppressed due to the nuclear translocation of nuclear factor-like 2 (Nrf2). Then the intracellular drug concentration was increased and the drug-resistant phenotype was reversed. Our findings improve current understanding of the biology of IGF-IR and MDR and have significant therapeutic implications on colorectal MDR cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI